Arena Pharmaceuticals, Inc. (OQ:ARNA)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ARNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Munshi Amit Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,800  
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -6,462 $59.12
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -13,931 $58.61
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -9,017 $57.52
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -5,390 $56.67
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,800 $14.60
May 22/20 May 21/20 Munshi Amit Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -50,000  
May 22/20 May 21/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -50,000 $55.00
May 22/20 May 21/20 Munshi Amit Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 50,000 $14.60
Mar 17/20 Mar 16/20 Stelzer Laurie Direct Ownership Employee Performance Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 6,300  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ARNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 22/20 Munshi Amit Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,800  
May 22/20 May 21/20 Munshi Amit Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -50,000  
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -6,462 $59.12
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -13,931 $58.61
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -9,017 $57.52
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -5,390 $56.67
May 22/20 May 22/20 Munshi Amit Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,800 $14.60
May 22/20 May 21/20 Munshi Amit Direct Ownership Common Stock S - Open market or private sale -50,000 $55.00
May 22/20 May 21/20 Munshi Amit Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 50,000 $14.60
Mar 18/20 Mar 15/20 Schmidt Joan Direct Ownership Employee Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 132,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ARNA

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)